Search research articles
Contact Us
Filters
Showing results (191-200 of 206) with videos related to
Page
of 21
Sort By:
NPJ Precision Oncology
|
May 17, 2024
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
Azra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Molecular Cancer Research : MCR
|
January 27, 2026
OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundance
Matthew J Bernard, Andrea Gallardo, Angel Ruiz, et al.
The Journal of Pathology
|
October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer
Radhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.
JCO Precision Oncology
|
October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer
David R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Cancer Research Communications
|
August 6, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
Hyun Jung Lee, Roman Gulati, Erolcan Sayar, et al.
Signal Transduction and Targeted Therapy
|
July 25, 2024
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation
Alvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
Adam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Biorxiv : the Preprint Server for Biology
|
February 8, 2024
LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancer
A Mandl, S Jasmine, Teg Krueger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies
Samir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Biorxiv : the Preprint Server for Biology
|
April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies
Samir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 206) with videos related to
Sort By:
Page
of 21
NPJ Precision Oncology
|
May 17, 2024
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
Azra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Molecular Cancer Research : MCR
|
January 27, 2026
OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundance
Matthew J Bernard, Andrea Gallardo, Angel Ruiz, et al.
The Journal of Pathology
|
October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer
Radhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.
JCO Precision Oncology
|
October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer
David R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Cancer Research Communications
|
August 6, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
Hyun Jung Lee, Roman Gulati, Erolcan Sayar, et al.
Signal Transduction and Targeted Therapy
|
July 25, 2024
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation
Alvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
Adam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Biorxiv : the Preprint Server for Biology
|
February 8, 2024
LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancer
A Mandl, S Jasmine, Teg Krueger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies
Samir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Biorxiv : the Preprint Server for Biology
|
April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies
Samir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Page
of 21